Caris Life Sciences, Inc. (CAI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 32.88M | 44.78M | 62.42M | 7.29M | -31.34M | 97.61M | 86.28M | 75.79M | 78.81M | 72.58M | 65.5M | 60.13M |
| Operating CF Margin % | 15.21% | 15.29% | 28.79% | 4.02% | -25.92% | 96.81% | 100.68% | 93.8% | 122.53% | 91.81% | 86.5% | 57.25% |
| Operating CF Growth % | 204.91% | - | - | - | - | 34.49% | 31.72% | 26.05% | 19.7% | 0.24% | 6.64% | 10.67% |
| Net Income | -510K | 81.96M | 24.32M | -71.79M | -102.58M | 51.16M | 37.94M | 35.74M | 14.25M | 15.44M | -626K | -1.33M |
| Depreciation & Amortization | 5.07M | 4.29M | 7.33M | 6.41M | 7.04M | 32.88M | 29.48M | 28.77M | 23.73M | 30.62M | 28.58M | 27.72M |
| Stock-Based Compensation | 0 | 13.37M | 13.65M | 28.29M | 14.69M | 566K | 593K | 540K | 359K | 615K | -73K | 874K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 4.41M | -2.27M | -940K | 6.39M | -1.89M | 377K | -3.5M |
| Other Non-Cash Items | 20.03M | 4.26M | 3.75M | 45.81M | 36.19M | -12.99M | -7.44M | -22.45M | 26.66M | 65.77M | 129.86M | 230.5M |
| Working Capital Changes | 8.29M | -59.1M | 13.36M | -1.44M | 13.32M | 21.6M | 27.97M | 34.13M | 7.43M | -37.98M | -92.62M | -194.13M |
| Change in Receivables | 21.62M | -91.02M | 24.19M | 29.13M | 7.91M | -15.74M | -2.88M | 488K | -775K | 7.33M | 32K | 4.41M |
| Change in Inventory | -13.33M | -9.61M | -8.52M | -4.68M | 2.06M | 42.62M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 16.37M | 12.23M | 0 | -186K | -1.74M | -6.41M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -10.34M | -5.09M | -7.09M | -1.39M | -2.69M | -515.36M | -83.46M | -144.11M | -50.57M | 14.07M | -175K | -2.91M |
| Capital Expenditures | -10.34M | -5.09M | -7.09M | -1.39M | -2.69M | -545.17M | -105.08M | -171.65M | -170.23M | -16.29M | -5.12M | -27.81M |
| CapEx % of Revenue | 4.78% | 1.74% | 3.27% | 0.76% | 2.22% | 540.7% | 122.62% | 212.43% | 264.66% | 20.61% | 6.76% | 26.48% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 29.82M | 21.62M | 27.54M | 119.66M | 30.37M | 4.95M | 24.9M |
| Cash from Financing | 824K | 3.4M | -21.1M | 681.4M | 1.28M | 428.81M | -12.06M | 62.42M | -344.3M | 219.96M | -129.71M | 4.16M |
| Debt Issued (Net) | -40K | 3.96M | -23K | 23.84M | -22K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 920K | 3.77M | -16.56M | 11.46M | -22K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | -7.41M | -7.41M | -7.4M | -6.66M | -6.63M | -2.21M | -2.21M |
| Share Repurchases | 0 | -91K | -16.56M | 0 | -22K | 0 | 0 | -12.79M | -7.95M | 0 | 0 | 0 |
| Other Financing | -56K | -4.33M | -4.51M | 646.1M | 1.33M | 436.22M | -4.66M | 69.82M | -337.64M | 226.59M | -127.5M | 6.37M |
| Net Change in Cash | 23.35M | 43.06M | 34.3M | 687.4M | -32.74M | 11.08M | -9.37M | -5.9M | -315.94M | 312.4M | -64.49M | 61.3M |
| Free Cash Flow | 22.53M | 39.69M | 55.33M | 5.9M | -34.03M | -447.56M | -18.8M | -95.86M | -91.42M | 56.28M | 60.38M | 32.31M |
| FCF Margin % | 10.42% | 13.55% | 25.52% | 3.25% | -28.14% | -443.89% | -21.94% | -118.64% | -142.13% | 71.2% | 79.74% | 30.77% |
| FCF Growth % | 166.22% | - | - | - | - | -895.17% | -131.14% | -396.64% | -1970.57% | 411.1% | 72.55% | 137.17% |
| FCF per Share | 0.08 | 0.02 | 0.19 | 0.02 | -0.13 | -25.53 | -1.08 | -5.47 | -5.09 | 3.18 | 3.43 | 1.85 |
| FCF Conversion (FCF/Net Income) | -64.46x | 0.55x | 2.57x | -0.10x | 0.31x | 1.91x | 2.27x | 2.12x | 5.53x | 4.70x | -104.63x | -45.21x |
| Interest Paid | 0 | 0 | 0 | 0 | 10.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |